There are many hopeful programs being developed within Telix, strengthening its footing. I am cheering for them all. However, two of them are my elephants in the room right now.
1. What if Zircaix gets approved (conservative revenue estimate 500m USD = 750m AUD) - doubling Telix's currently estimated revenue outlook?
2. What if the phase 3 interim readout of ProstACT GLOBAL (TLX 591) stays roughly within the ballpark of prior overall survival at 42 months (e.g. 35 -45 months)?
Wouldn't you expect a doubling in market cap from number 1 and a further doubling from those heights with number 2, let's say within the next 2 years?
Understanding Telix, page-1076
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.13 |
Change
-0.340(1.75%) |
Mkt cap ! $6.401B | |||
| Open | High | Low | Value | Volume |
| $19.41 | $19.46 | $18.81 | $121.0M | 6.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7316 | $19.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.13 | 6814 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |